共 321 条
[71]
Bezafibrates cause moderate, reversible impairment in renal function in patients without prior renal disease
[J].
NEPHRON CLINICAL PRACTICE,
2005, 100 (04)
:C120-C125
[73]
Cheung MC, 1999, ATHEROSCLEROSIS, V142, P201
[77]
*CHMP PHARM WORK P, 2007, ASS REP BEN RISK FIB
[80]
Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
[J].
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION,
2001, 285 (19)
:2486-2497